Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens.

[1]  Liang Cheng,et al.  Perspectives on testicular germ cell neoplasms. , 2017, Human pathology.

[2]  J P Donohue,et al.  Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  N. Hanna,et al.  Testicular cancer--discoveries and updates. , 2014, The New England journal of medicine.

[4]  T. Ulbright,et al.  Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes. , 2014, The Journal of urology.

[5]  Richard Sylvester,et al.  International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers , 1997 .

[6]  R. Fimmers,et al.  Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  B. Delahunt,et al.  Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists , 2015, Histopathology.

[8]  S. Shikanov,et al.  Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009 , 2015, World Journal of Urology.

[9]  Lee,et al.  The value of central histopathological review of testicular tumours before treatment , 1999, BJU international.

[10]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[11]  HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONE , 1987, The Lancet.

[12]  K. Lu.  Surveillance for Stage I Nonseminoma Testicular Cancer: Outcomes and Long-Term Follow-Up in a Population-Based Cohort. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Horwich,et al.  Guidelines on Testicular Cancer: 2015 Update. , 2015, European urology.

[14]  P. Kay,et al.  Second opinion pathology in tertiary care of patients with urologic malignancies. , 2011, Urologic oncology.

[15]  L. Einhorn,et al.  Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Habbema,et al.  Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Raghavan,et al.  The impact of histological review on clinical management of testicular cancer. , 1993, British journal of urology.

[18]  N. Deshmukh,et al.  The continued value of central histopathological review of testicular tumours , 2007, Histopathology.

[19]  N. Hanna,et al.  Testicular cancer: a reflection on 50 years of discovery. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  W. Lowrance,et al.  Epidemiology and Diagnosis of Testis Cancer. , 2015, The Urologic clinics of North America.

[21]  G. Paner,et al.  Clinicopathologic Analysis of Choriocarcinoma as a Pure or Predominant Component of Germ Cell Tumor of the Testis , 2014, The American journal of surgical pathology.

[22]  T. Choueiri,et al.  Management of clinical stage I nonseminomatous germ cell testicular cancer. , 2007, The Urologic clinics of North America.

[23]  F. Mostofi,et al.  Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Grignon,et al.  Molecular Genetic Evidence Supporting the Origin of Somatic-type Malignancy and Teratoma From the Same Progenitor Cell , 2012, The American journal of surgical pathology.

[25]  M. Colecchia,et al.  Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection. , 2011, The Journal of urology.

[26]  P. Albers,et al.  Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  C. Bokemeyer,et al.  Testicular Germ Cell Tumours , 2017 .

[28]  T. Ulbright,et al.  Adult primary pure teratoma of the testis. The Indiana experience , 1995, Cancer.

[29]  V. Schuermans,et al.  IMPAIRED NEUTROPHIL PHAGOCYTOSIS , 1974 .